1.
Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for
Study
1.2.3. Key Market
Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the
Market
3.2. Overview of Key
Market Segmentations
3.3. Overview of Key
Market Players
3.4. Overview of Key
Regions/Countries
3.5. Overview of Market
Drivers, Challenges, Trends
4.
Voice of Customer
5.
Clinical Trial Analysis
5.1. Ongoing Clinical
Trials
5.2. Completed Clinical
Trials
5.3. Terminated Clinical Trials
5.4. Breakdown of
Pipeline, By Development Phase
5.5. Breakdown of
Pipeline, By Status
5.6. Breakdown of
Pipeline, By Study Type
5.7. Breakdown of
Pipeline, By Country
5.8. Clinical Trials Heat
Map
6. Global Dementia and
Alzheimer’s Disease Treatment Market Outlook
6.1.
Market Size & Forecast
6.1.1. By Value
6.2.
Market Share & Forecast
6.2.1. By Drug Class (Cholinergic/ Cholinesterase (ChE) Inhibitors [Donepezil, Galantamine,
Rivastigmine], Memantine, Combination Drugs [Memantine & Donepezil]
6.2.2. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and
Online Pharmacies)
6.2.3. By Company (2022)
6.2.4. By Region
6.3.
Market Attractiveness Index
7. Asia-Pacific Dementia
and Alzheimer’s Disease Treatment Market Outlook
7.1.
Market Size & Forecast
7.1.1. By Value
7.2.
Market Share & Forecast
7.2.1. By Drug Class
7.2.2. By Distribution
Channel
7.2.3. By Country
7.3.
Asia-Pacific: Country Analysis
7.3.1. China Dementia and
Alzheimer’s Disease Treatment Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Drug Class
7.3.1.2.2.
By Distribution Channel
7.3.2. India Dementia and
Alzheimer’s Disease Treatment Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Drug Class
7.3.2.2.2.
By Distribution Channel
7.3.3. Australia Dementia
and Alzheimer’s Disease Treatment Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Drug Class
7.3.3.2.2.
By Distribution Channel
7.3.4. Japan Dementia and
Alzheimer’s Disease Treatment Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Drug Class
7.3.4.2.2.
By Distribution Channel
7.3.5. South Korea Dementia
and Alzheimer’s Disease Treatment Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Drug Class
7.3.5.2.2.
By Distribution Channel
8. Europe Dementia and
Alzheimer’s Disease Treatment Market Outlook
8.1.
Market Size & Forecast
8.1.1. By Value
8.2.
Market Share & Forecast
8.2.1. By Drug Class
8.2.2. By Distribution
Channel
8.2.3. By Country
8.3.
Europe: Country Analysis
8.3.1. France Dementia and
Alzheimer’s Disease Treatment Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Drug Class
8.3.1.2.2.
By Distribution Channel
8.3.2. Germany Dementia and
Alzheimer’s Disease Treatment Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Drug Class
8.3.2.2.2.
By Distribution Channel
8.3.3. United Kingdom Dementia
and Alzheimer’s Disease Treatment Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Drug Class
8.3.3.2.2.
By Distribution Channel
8.3.4. Italy Dementia and
Alzheimer’s Disease Treatment Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Drug Class
8.3.4.2.2.
By Distribution Channel
8.3.5. Spain Dementia and
Alzheimer’s Disease Treatment Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Drug Class
8.3.5.2.2.
By Distribution Channel
9. North America Dementia
and Alzheimer’s Disease Treatment Market Outlook
9.1.
Market Size & Forecast
9.1.1. By Value
9.2.
Market Share & Forecast
9.2.1. By Drug Class
9.2.2. By Distribution
Channel
9.2.3. By Country
9.3.
North America: Country Analysis
9.3.1. United States Dementia
and Alzheimer’s Disease Treatment Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Drug Class
9.3.1.2.2.
By Distribution Channel
9.3.2. Mexico Dementia and
Alzheimer’s Disease Treatment Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Drug Class
9.3.2.2.2.
By Distribution Channel
9.3.3. Canada Dementia and
Alzheimer’s Disease Treatment Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Drug Class
9.3.3.2.2.
By Distribution Channel
10. South America Dementia
and Alzheimer’s Disease Treatment Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value
10.2.
Market Share & Forecast
10.2.1. By Drug Class
10.2.2. By Distribution
Channel
10.2.3. By Country
10.3.
South America: Country Analysis
10.3.1. Brazil Dementia and
Alzheimer’s Disease Treatment Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1.
By Drug Class
10.3.1.2.2.
By Distribution Channel
10.3.2. Argentina Dementia
and Alzheimer’s Disease Treatment Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1.
By Drug Class
10.3.2.2.2.
By Distribution Channel
10.3.3. Colombia Dementia
and Alzheimer’s Disease Treatment Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1.
By Drug Class
10.3.3.2.2.
By Distribution Channel
11. Middle East and
Africa Dementia and Alzheimer’s Disease Treatment Market Outlook
11.1.
Market Size & Forecast
11.1.1. By Value
11.2.
Market Share & Forecast
11.2.1. By Drug Class
11.2.2. By Distribution
Channel
11.2.3. By Country
11.3.
MEA: Country Analysis
11.3.1. South Africa Dementia
and Alzheimer’s Disease Treatment Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1.
By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1.
By Drug Class
11.3.1.2.2.
By Distribution Channel
11.3.2. Saudi Arabia Dementia
and Alzheimer’s Disease Treatment Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1.
By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1.
By Drug Class
11.3.2.2.2.
By Distribution Channel
11.3.3. UAE Dementia and
Alzheimer’s Disease Treatment Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1.
By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1.
By Drug Class
11.3.3.2.2.
By Distribution Channel
12.
Market Dynamics
12.1.
Drivers
12.2.
Challenges
13.
Market Trends & Developments
14.
Competitive Landscape
14.1.
Merz
Pharma GmbH & Co. KGaA
14.2.
Novartis
AG
14.3.
Pfizer,
Inc.
14.4.
Ono
Pharmaceutical Co., Ltd.
14.5.
Johnson
& Johnson Services, Inc.
14.6.
H. Lundbeck
A/S
14.7.
F.
Hoffmann-La Roche Ltd.
14.8.
AbbVie
Inc.
14.9.
Eli Lilly
and Company
14.10.
Corium,
Inc.
15. Strategic Recommendations